Our immunostaining also confirmed intratumor heterogeneity of ALK rearrangement in primary tumors, and to our knowledge, this is the first report on ALK rearrangement in lung cancer at metastatic sites versus primary sites, which showed molecular differences. This evidence concerns the gene ALK and lung carcinoma.